PMID- 33515165 OWN - NLM STAT- MEDLINE DCOM- 20210917 LR - 20220130 IS - 2212-5469 (Electronic) IS - 1738-2696 (Print) IS - 1738-2696 (Linking) VI - 18 IP - 1 DP - 2021 Feb TI - Nitric Oxide Produced by the Antioxidant Activity of Verapamil Improves the Acute Wound Healing Process. PG - 179-186 LID - 10.1007/s13770-020-00308-x [doi] AB - BACKGROUND: Verapamil is used in the treatment of hypertension, angina pectoris, cardiac arrhythmia, hypertrophic scars, and keloids to block transmembrane calcium ion flux. Verapamil has antioxidant activity, which enhances the production of nitric oxide (NO). NO promotes the proliferation of fibroblasts, keratinocytes, endothelial cells, and epithelial cells during wound healing. In this study, we investigated the effect of verapamil and its antioxidant properties on the enhancement of acute wound healing via NO. METHODS: A full-thickness wound healing model was created on the rat dorsal with a silicone ring. The wound closure rate was estimated every 2 days for 14 days. A histological study was performed to evaluate wound healing. Immunofluorescence staining was analyzed for angiogenesis. The expressions of collagen type I (COL I), collagen type III (COL III), and vascular endothelial growth factor (VEGF) were assessed by Western blot. Real-time polymerase chain reaction (qRT-PCR) was performed to examine the expression of endothelial NO synthase and inducible NO synthase, which are related to antioxidant activity in the process of wound healing. RESULTS: The wound closure rate was faster in the verapamil group compared to the control and silicone groups. Histologic analysis revealed capillaries and stratum basale in the verapamil group. Immunofluorescence staining was shown vessel formation in the verapamil group. Western blot and qRT-PCR analysis revealed high expression levels of COL I, VEGF, eNOS, and FGF in the verapamil. CONCLUSION: Verapamil's antioxidant activity enhances NO production in acute wound healing. We suggest that verapamil can be used to promote acute wound healing. FAU - Han, Yu Na AU - Han YN AD - Department of Biomedicine and Health Sciences, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seoul, 06591, Republic of Korea. AD - Department of Plastic and Reconstructive Surgery, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea. FAU - Lee, Yoon Jae AU - Lee YJ AD - Department of Plastic and Reconstructive Surgery, College of Medicine, Yeouido St. Mary's Hospital, The Catholic University of Korea, 1661-7575, Yeongdeungpo-gu, Seoul, Republic of Korea. FAU - Kim, Ki Joo AU - Kim KJ AD - Department of Plastic and Reconstructive Surgery, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea. FAU - Lee, Su Jin AU - Lee SJ AD - Department of Biomedicine and Health Sciences, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seoul, 06591, Republic of Korea. AD - Department of Plastic and Reconstructive Surgery, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea. FAU - Choi, Jang Youn AU - Choi JY AD - Department of Plastic and Reconstructive Surgery, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea. FAU - Moon, Suk-Ho AU - Moon SH AD - Department of Plastic and Reconstructive Surgery, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea. FAU - Rhie, Jong Won AU - Rhie JW AUID- ORCID: 0000-0002-9398-8059 AD - Department of Biomedicine and Health Sciences, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seoul, 06591, Republic of Korea. rhie@catholic.ac.kr. AD - Department of Plastic and Reconstructive Surgery, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea. rhie@catholic.ac.kr. LA - eng GR - 2017M3A9E2060428/National Research Foundation of Korea/ GR - 10062127/Korea Evaluation Institute of Industrial Technology/ PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20210129 PL - Korea (South) TA - Tissue Eng Regen Med JT - Tissue engineering and regenerative medicine JID - 101699923 RN - 0 (Antioxidants) RN - 0 (Vascular Endothelial Growth Factor A) RN - 31C4KY9ESH (Nitric Oxide) RN - CJ0O37KU29 (Verapamil) SB - IM MH - Animals MH - *Antioxidants/pharmacology MH - Endothelial Cells MH - *Nitric Oxide MH - Rats MH - Vascular Endothelial Growth Factor A MH - Verapamil/pharmacology MH - Wound Healing PMC - PMC7862477 OTO - NOTNLM OT - Antioxidant activity OT - Nitric oxide OT - Verapamil OT - Wound healing COIS- The authors have no financial conflicts of interest. EDAT- 2021/01/31 06:00 MHDA- 2021/09/18 06:00 PMCR- 2022/01/29 CRDT- 2021/01/30 05:36 PHST- 2020/06/22 00:00 [received] PHST- 2020/10/13 00:00 [accepted] PHST- 2020/09/17 00:00 [revised] PHST- 2021/01/31 06:00 [pubmed] PHST- 2021/09/18 06:00 [medline] PHST- 2021/01/30 05:36 [entrez] PHST- 2022/01/29 00:00 [pmc-release] AID - 10.1007/s13770-020-00308-x [pii] AID - 308 [pii] AID - 10.1007/s13770-020-00308-x [doi] PST - ppublish SO - Tissue Eng Regen Med. 2021 Feb;18(1):179-186. doi: 10.1007/s13770-020-00308-x. Epub 2021 Jan 29.